CLINICAL RESEARCH: HEART FAILURE
Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart FailureA Report From the OPTIMIZE-HF Registry
Gregg C. Fonarow, MD, FACC*,*,
Wendy Gattis Stough, PharmD ,
William T. Abraham, MD, FACC ,
Nancy M. Albert, PhD, RN ,
Mihai Gheorghiade, MD, FACC||,
Barry H. Greenberg, MD, FACC¶,
Christopher M. OConnor, MD, FACC#,
Jie Lena Sun, MS**,
Clyde W. Yancy, MD, FACC ,
James B. Young, MD, FACC for the OPTIMIZE-HF Investigators and Hospitals
* Department of Medicine, UCLA Medical Center, Los Angeles, California
Department of Medicine, Duke University Medical Center, Durham, North Carolina, and Department of Clinical Research, Campbell University School of Pharmacy, Research Triangle Park, North Carolina
Division of Cardiology, Ohio State University, Columbus, Ohio
George M. and Linda H. Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio
|| Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
¶ Department of Medicine, USCD Medical Center, San Diego, California
# Division of Cardiology, Duke University Medical Center/Duke Clinical Research Institute, Durham, North Carolina
** Duke Clinical Research Institute, Durham, North Carolina
 Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas (formerly Department of Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas)
 Department of Cardiovascular Medicine, Heart Failure Section, Cleveland Clinic Foundation, Cleveland, Ohio.
Manuscript received December 12, 2006;
revised manuscript received April 20, 2007,
accepted April 23, 2007.
* Reprint requests and correspondence: Dr. Gregg C. Fonarow, Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, 10833 LeConte Avenue, Room 47-123 CHS, Los Angeles, California 90095-1679. (Email: gfonarow{at}mednet.ucla.edu).
Objectives: We sought to evaluate the characteristics, treatments, and outcomes of patients with preserved and reduced systolic function heart failure (HF).
Background: Heart failure with preserved systolic function (PSF) is common but not well understood.
Methods: This analysis of the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry compared 20,118 patients with left ventricular systolic dysfunction (LVSD) and 21,149 patients with PSF (left ventricular ejection fraction [EF] 40%). Sixty- to 90-day follow-up was obtained in a pre-specified 10% sample of patients. Analyses of patients with PSF defined as EF >50% were also performed for comparison.
Results: Patients with PSF (EF 40%) were more likely to be older, female, and Caucasian and to have a nonischemic etiology. Although length of hospital stay was the same in both groups, risk of in-hospital mortality was lower in patients with PSF (EF 40%) (2.9% vs. 3.9%; p < 0.0001). During 60- to 90-day post-discharge follow-up, patients with PSF (EF 40%) had a similar mortality risk (9.5% vs. 9.8%; p = 0.459) and rehospitalization rates (29.2% vs. 29.9%; p = 0.591) compared with patients with LVSD. Findings were comparable with those with PSF defined as EF >50%. In a risk- and propensity-adjusted model, there were no significant relationships between discharge use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker or beta-blocker and 60- to 90-day mortality and rehospitalization rates in patients with PSF.
Conclusions: Data from the OPTIMIZE-HF registry reveal a high prevalence of HF with PSF, and these patients have a similar post-discharge mortality risk and equally high rates of rehospitalization as patients with HF and LVSD. Despite the burden to patients and health care systems, data are lacking on effective management strategies for patients with HF and PSF. (Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure [OPTIMIZE-HF]); http://www.clinicaltrials.gov/ct/show/NCT00344513?order=1; NCT00344513
[ClinicalTrials.gov]
)
|
Abbreviations and Acronyms
| | ACE = angiotensin-converting enzyme | | ARB = angiotensin receptor blocker | | EF = ejection fraction | | HF = heart failure | | LVSD = left ventricular systolic dysfunction | | PSF = preserved systolic function |
|
Related Article
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2007 50: A33-A34.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
C. C. Welles, I. A. Ku, D. M. Kwan, M. A. Whooley, N. B. Schiller, and M. P. Turakhia
Left Atrial Function Predicts Heart Failure Hospitalization in Subjects With Preserved Ejection Fraction and Coronary Heart Disease: Longitudinal Data From the Heart and Soul Study
J. Am. Coll. Cardiol.,
February 14, 2012;
59(7):
673 - 680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Postmus, D. J. van Veldhuisen, T. Jaarsma, M. L. Luttik, J. Lassus, A. Mebazaa, M. S. Nieminen, V.-P. Harjola, J. Lewsey, E. Buskens, et al.
The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure
Eur J Heart Fail,
February 1, 2012;
14(2):
168 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Harinstein, J. D. Flaherty, G. C. Fonarow, M. R. Mehra, R. M. Lang, R. J. Kim, J. G. Cleland, B. P. Knight, P. S. Pang, R. O. Bonow, et al.
Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period
Heart,
October 1, 2011;
97(19):
1607 - 1618.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. West, L. Liang, G. C. Fonarow, R. Kociol, R. M. Mills, C. M. O'Connor, and A. F. Hernandez
Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry
Eur J Heart Fail,
September 1, 2011;
13(9):
945 - 952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Meune, K. Wahbi, D. Duboc, and S. Weber
Meta-Analysis of Renin-Angiotensin-Aldosterone Blockade for Heart Failure in Presence of Preserved Left Ventricular Function
Journal of Cardiovascular Pharmacology and Therapeutics,
September 1, 2011;
16(3-4):
368 - 375.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Meta-analysis Global Group in Chronic Heart Failur
The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis
Eur. Heart J.,
August 6, 2011;
(2011)
ehr254v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Borlaug and M. M. Redfield
Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum
Circulation,
May 10, 2011;
123(18):
2006 - 2014.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gheorghiade and E. Braunwald
A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
JAMA,
April 27, 2011;
305(16):
1702 - 1703.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Holland, D. J. Kumbhani, S. H. Ahmed, and T. H. Marwick
Effects of Treatment on Exercise Tolerance, Cardiac Function, and Mortality in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
J. Am. Coll. Cardiol.,
April 19, 2011;
57(16):
1676 - 1686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Komajda, P. E. Carson, S. Hetzel, R. McKelvie, J. McMurray, A. Ptaszynska, M. R. Zile, D. DeMets, and B. M. Massie
Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction: Findings From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-PRESERVE)
Circ Heart Fail,
January 1, 2011;
4(1):
27 - 35.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. P. Lam, E. Donal, E. Kraigher-Krainer, and R. S. Vasan
Epidemiology and clinical course of heart failure with preserved ejection fraction
Eur J Heart Fail,
January 1, 2011;
13(1):
18 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gheorghiade, M. Albaghdadi, F. Zannad, G. C. Fonarow, M. Bohm, C. Gimpelewicz, J. Botha, S. Moores, E. F. Lewis, H. Rattunde, et al.
Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)
Eur J Heart Fail,
January 1, 2011;
13(1):
100 - 106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Metra, D. Brutsaert, L. Dei Cas, and M. Gheorghiade
Chapter 49 Acute heart failure: epidemiology, classification, and pathophysiology
The ESC Textbook of Acute and Intensive Cardiac Care,
December 1, 2010;
1(1):
med-9780199584314-chapter - med-9780199584314-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Weintraub, S. P. Collins, P. S. Pang, P. D. Levy, A. S. Anderson, C. Arslanian-Engoren, W. B. Gibler, J. K. McCord, M. B. Parshall, G. S. Francis, et al.
Acute Heart Failure Syndromes: Emergency Department Presentation, Treatment, and Disposition: Current Approaches and Future Aims: A Scientific Statement From the American Heart Association
Circulation,
November 9, 2010;
122(19):
1975 - 1996.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Collins, P. S. Pang, C. J. Lindsell, D. N. Kyriacou, A. B. Storrow, J. E. Hollander, J. Douglas Kirk, C. D. Miller, R. Nowak, W. Frank Peacock, et al.
International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes
Eur J Heart Fail,
November 1, 2010;
12(11):
1253 - 1260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Albert, K. Trochelman, J. Li, and S. Lin
Signs and Symptoms of Heart Failure: Are You Asking the Right Questions?
Am. J. Crit. Care.,
September 1, 2010;
19(5):
443 - 452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Jong, R. McKelvie, and S. Yusuf
Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?
BMJ,
August 25, 2010;
341(aug25_2):
c4202 - c4202.
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Davenport, S. D. Anker, A. Mebazaa, A. Palazzuoli, G. Vescovo, R. Bellomo, P. Ponikowski, I. Anand, N. Aspromonte, S. Bagshaw, et al.
ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference
Nephrol. Dial. Transplant.,
July 1, 2010;
25(7):
2077 - 2089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. B. Popovic and B. Griffin
Diastolic stress testing: a new trick to evaluate the ageing heart
Heart,
June 1, 2010;
96(12):
906 - 907.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Chung, R. P. Katra, S. Ghio, J. Bax, B. Gerritse, K. Hilpisch, B. J. Peterson, D. S. Feldman, and W. T. Abraham
Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction >35%: a PROSPECT trial substudy
Eur J Heart Fail,
June 1, 2010;
12(6):
581 - 587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Dunlay, M. Gheorghiade, K. J. Reid, L. A. Allen, P. S. Chan, P. J. Hauptman, F. Zannad, A. P. Maggioni, K. Swedberg, M. A. Konstam, et al.
Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial
Eur J Heart Fail,
April 1, 2010;
12(4):
367 - 374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Zile, W. H. Gaasch, I. S. Anand, M. Haass, W. C. Little, A. B. Miller, J. Lopez-Sendon, J. R. Teerlink, M. White, J. J. McMurray, et al.
Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial
Circulation,
March 30, 2010;
121(12):
1393 - 1405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Paulus and J. J.M. van Ballegoij
Treatment of Heart Failure With Normal Ejection Fraction: An Inconvenient Truth!
J. Am. Coll. Cardiol.,
February 9, 2010;
55(6):
526 - 537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Lainchbury, R. W. Troughton, K. M. Strangman, C. M. Frampton, A. Pilbrow, T. G. Yandle, A. K. Hamid, M. G. Nicholls, and A. M. Richards
N-Terminal Pro-B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure: Results From the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) Trial
J. Am. Coll. Cardiol.,
January 5, 2010;
55(1):
53 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sarraf, A. Masoumi, and R. W. Schrier
Cardiorenal Syndrome in Acute Decompensated Heart Failure
Clin. J. Am. Soc. Nephrol.,
December 1, 2009;
4(12):
2013 - 2026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Levy, H. Ye, S. Compton, P. S. Chan, G. L. Larkin, R. D. Welch, and for the American Heart Association National Regist
Factors Associated With Neurologically Intact Survival for Patients With Acute Heart Failure and In-Hospital Cardiac Arrest
Circ Heart Fail,
November 1, 2009;
2(6):
572 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Somaratne, C. Berry, J. J.V. McMurray, K. K. Poppe, R. N. Doughty, and G. A. Whalley
The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis
Eur J Heart Fail,
September 1, 2009;
11(9):
855 - 862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Curtis, M. A. Greiner, B. G. Hammill, L. D. DiMartino, A. M. Shea, A. F. Hernandez, and G. C. Fonarow
Representativeness of a National Heart Failure Quality-of-Care Registry: Comparison of OPTIMIZE-HF and Non-OPTIMIZE-HF Medicare Patients
Circ Cardiovasc Qual Outcomes,
July 1, 2009;
2(4):
377 - 384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hsich, E. Z. Gorodeski, R. C. Starling, E. H. Blackstone, H. Ishwaran, and M. S. Lauer
Importance of Treadmill Exercise Time as an Initial Prognostic Screening Tool in Patients With Systolic Left Ventricular Dysfunction
Circulation,
June 30, 2009;
119(25):
3189 - 3197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gheorghiade and P. S. Pang
Acute Heart Failure Syndromes
J. Am. Coll. Cardiol.,
February 17, 2009;
53(7):
557 - 573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Donal, L. H. Lund, C. Linde, M. Edner, S. Lafitte, H. Persson, F. Bauer, J. Ohrvik, P.-V. Ennezat, C. Hage, et al.
Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction
Eur J Heart Fail,
February 1, 2009;
11(2):
198 - 204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Flaherty, J. J. Bax, L. De Luca, J. S. Rossi, C. J. Davidson, G. Filippatos, P. P. Liu, M. A. Konstam, B. Greenberg, M. R. Mehra, et al.
Acute Heart Failure Syndromes in Patients With Coronary Artery Disease: Early Assessment and Treatment
J. Am. Coll. Cardiol.,
January 20, 2009;
53(3):
254 - 263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Rossi, J. D. Flaherty, G. C. Fonarow, E. Nunez, W. Gattis Stough, W. T. Abraham, N. M. Albert, B. H. Greenberg, C. M. O'Connor, C. W. Yancy, et al.
Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: A report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)
Eur J Heart Fail,
December 1, 2008;
10(12):
1215 - 1223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Little
Hypertension, Heart Failure, and Ejection Fraction
Circulation,
November 25, 2008;
118(22):
2223 - 2223.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ronco, M. Haapio, A. A. House, N. Anavekar, and R. Bellomo
Cardiorenal Syndrome
J. Am. Coll. Cardiol.,
November 4, 2008;
52(19):
1527 - 1539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Di Tullio
Diastolic Dysfunction: Does Ethnicity Matter?
J. Am. Coll. Cardiol.,
September 16, 2008;
52(12):
1022 - 1023.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. O. Bonow
Measuring Quality in Heart Failure: Do We Have the Metrics?
Circ Cardiovasc Qual Outcomes,
September 1, 2008;
1(1):
9 - 11.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Shah and M. Gheorghiade
Heart Failure With Preserved Ejection Fraction: Treat Now by Treating Comorbidities
JAMA,
July 23, 2008;
300(4):
431 - 433.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Ross, G. K. Mulvey, B. Stauffer, V. Patlolla, S. M. Bernheim, P. S. Keenan, and H. M. Krumholz
Statistical Models and Patient Predictors of Readmission for Heart Failure: A Systematic Review
Arch Intern Med,
July 14, 2008;
168(13):
1371 - 1386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Beohar, A. K. Erdogan, D. C. Lee, H. N. Sabbah, M. J. Kern, J. Teerlink, R. O. Bonow, and M. Gheorghiade
Acute Heart Failure Syndromes and Coronary Perfusion
J. Am. Coll. Cardiol.,
July 1, 2008;
52(1):
13 - 16.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Fonarow, C. W. Yancy, N. M. Albert, A. B. Curtis, W. G. Stough, M. Gheorghiade, J. T. Heywood, M. L. McBride, M. R. Mehra, C. M. O'Connor, et al.
Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF
Circ Heart Fail,
July 1, 2008;
1(2):
98 - 106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J.V. McMurray, P. E. Carson, M. Komajda, R. McKelvie, M. R. Zile, A. Ptaszynska, C. Staiger, J. M. Donovan, and B. M. Massie
Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial
Eur J Heart Fail,
February 1, 2008;
10(2):
149 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Wolfel
Can We Predict and Prevent the Onset of Acute Decompensated Heart Failure?
Circulation,
October 2, 2007;
116(14):
1526 - 1529.
[Full Text]
[PDF]
|
 |
|
|